Last updated on December 2019

A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies


Find a site near you

Start Over

Facey Medical Foundation /ID# 203136

Mission Hills, CA United States
  Connect »

Ucsd /Id# 164910

San Diego, CA United States
  Connect »

Delta Waves, Inc. /ID# 164776

Colorado Springs, CO United States
  Connect »

Borland-Groover Clinic /ID# 203499

Jacksonville, FL United States
  Connect »

Advanced Research Institute /ID# 164921

New Port Richey, FL United States
  Connect »

DuPage Medical Group /ID# 205328

Downers Grove, IL United States
  Connect »

Aquiant Research /ID# 205503

New Albany, IN United States
  Connect »

Tri-State Gastroenterology /ID# 165496

Crestview Hills, KY United States
  Connect »

CroNOLA, LLC /ID# 164823

Houma, LA United States
  Connect »

NY Scientific /ID# 164931

Brooklyn, NY United States
  Connect »

Gastro One /ID# 164826

Germantown, TN United States
  Connect »

Sagact Pllc /Id# 169755

San Antonio, TX United States
  Connect »

Care Access Research /ID# 164794

Salt Lake City, UT United States
  Connect »

Cemic /Id# 169182

Buenos Aires, Argentina
  Connect »

Gedyt /ID# 210020

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Crchum /Id# 170120

Montreal, QC Canada
  Connect »

Hospital Italiano de Buenos Aires /ID# 215541

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

LLC Novaya Klinika /ID# 206616

Pyatigorsk, Russian Federation
  Connect »

Llc Olla-Med /Id# 208720

Moscow, Russian Federation
  Connect »

PMI Euromedservice /ID# 206610

Pushkin, Russian Federation
  Connect »

Dr JP Wright /ID# 170887

Cape Town, South Africa
  Connect »